Loading
Latest filing published 19 Feb 2014 for NephroGenex, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Robert R. Seltzer discloses dealings in NephroGenex, Inc. to SEC (Form 4). The record holds 4 filings, all for trades on 14 February 2014.
Every open-market trade on record is a purchase: 1 purchase worth €6.9M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.
On 19 February 2014 came the latest disclosure, a transaction in NephroGenex, Inc. The last purchase on record was published on 19 February 2014, which is 4,630 days ago. Typically, a trade is published a median of 5 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations